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Abstract
Background: Loss to follow-up (LTF) after antiretroviral therapy (ART) initiation is common in HIV clinics. We examined the
effect of availability of adherence support and active patient outreach services on patient attrition following ART initiation.
Methods and Findings: This ecologic study examined clinic attrition rates (total attrition, LTF, and death) among 232,389
patients initiating ART at 349 clinics during 2004–2008 in 10 sub-Saharan African countries, and cohort attrition (proportion
retained at 6 and 12 months after ART initiation) among a subset of patients with follow-up information (n=83,389). Log-
linear regression compared mean rates of attrition, LTF, and death between clinics with and without adherence support and
outreach services. Cumulative attrition, LTF, and death rates were 14.2, 9.2, and 4.9 per 100 person-years on ART,
respectively. In multivariate analyses, clinic availability of .2 adherence support services was marginally associated with
lower attrition rates (RRadj=0.59, 95%CI: 0.35–1.0). Clinics with availability of counseling services (RRadj=0.62, 95%CI: 0.42–
0.92), educational materials (RRadj=0.73, 95%CI: 0.63–0.85), reminder tools (RRadj=0.79, 95%CI: 0.64–0.97), and food rations
(RRadj=0.72, 95%CI: 0.58–0.90) had significantly lower attrition, with similar results observed for LTF. Outreach services were
not significantly associated with attrition. In cohort analyses, attrition was significantly lower at clinics offering .2
adherence support services (RRadj,6m=0.84, 95%CI: 0.73–0.96), dedicated pharmacy services (RRadj,6m=0.78, 95%CI: 0.69–
0.90), and active patient outreach (RRadj,6m=0.85, 95%CI: 0.73–0.99). Availability of food rations was marginally associated
with increased retention at 6 (RRadj,6m =0.82, 95%CI: 0.64–1.05) but not 12 months (RRadj,12m =0.98, 95%CI: 0.78–1.21).
Conclusions: Availability of adherence support services, active patient outreach and food rations at HIV care clinics may
improve retention following ART initiation.
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Introduction
Adherence to antiretroviral therapy (ART) and long-term
retention in care is essential for optimal treatment outcomes.
Identifying modifiable clinic-level factors associated with patient
retention and survival may suggest feasible points of intervention.
Two reviews of patients initiated on ART in sub-Saharan Africa
reported high non-retention six (12%–45%) and 12 (10%–51%)
months after ART initiation with substantial variability across
clinics [1,2]. Studies tracing patients lost to follow-up (LTF) have
found high unascertained deaths and transfers [3–5], suggesting
both contribute substantially to LTF.
Services focusing on barriers to medication and care adherence,
including forgetfulness [6–10], lack of knowledge about the
importance of adherence [6–12], fear of increased appetite
coupled with food insecurity[10,12–14], and stigma [10–13] may
improve retention by increasing survival and reducing LTF, but
their effectiveness in a diverse service delivery context is largely
unknown. Two studies in resource-limited settings have found
active outreach associated with lower LTF and more complete
vital status ascertainment [15,16].
This study used routinely-collected aggregate (ecologic) data
collected from HIV care and treatment clinics in 10 sub-Saharan
African countries to investigate whether the availability of clinic
services targeting adherence to ART medication and retention in
care was associated with better retention after ART initiation.
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Study Population
All HIV care and treatment programs supported by the U.S.
President’sEmergencyPlanforAIDSRelief(PEPFAR)arerequired
to report to the U.S. Government aggregate data summarizing
characteristicsofpatientsreceivingHIVcareandtreatmentatthese
clinics. Our study used aggregate (ecologic) clinic-level information
fromHIV-positivepatientsreceivingantiretroviraltherapyatclinics
supportedbyICAP-ColumbiaUniversityin10sub-SaharanAfrican
countries (Cote d’Ivoire, Ethiopia, Kenya, Lesotho, Mozambique,
Nigeria, Rwanda, South Africa, Tanzania, Zambia) were included.
EachclinicisgovernedbynationalHIVcareguidelinesandprovides
free ART. Information on clinic characteristics was collected for
routine monitoring and evaluation purposes by ICAP-staff through
interviews conducted with clinic staff. No patient-level information
was used in this study. The use of these routine monitoring and
evaluation data for this study was approved as nonhuman subjects
research by the US Centers for Disease Control and Prevention
(CDC) and the Institutional Review Board of Columbia University
Medical Center.
We included clinics providing ART services during January
2004–December 2008 that reported quarterly care and treatment
indicators for at least three consecutive quarters and completed a
site assessment survey. Of the 392 clinics supported by ICAP
during 2004–2008, 349 (89%) were included, representing over
232,000 patients initiating ART. Six and 12 month follow-up data
were also available on 1,097 cohorts of patients (N =83,389)
initiating ART in 3 month quarterly calendar periods, and were
included in cohort analyses to assess retention on ART.
Data Sources
Threesourcesofdatawereused:(1)cumulativeclinic-leveldataon
thenumberofpatientsinitiatingART,LTF,andreportedashaving
died or transferred (reported quarterly); (2) cohort-level data on the
proportion of persons initiating ART in a quarter who remained on
ART six- and 12-months after ART initiation (also reported
quarterly), and (3) a structured survey administered to clinic staff
measuring clinic-level characteristics.
Aggregate clinic-level outcome data. Aggregateclinic-level
data were obtained from routinely-collected PEPFAR Track 1.0
quarterlyprogramindicators,manuallytalliedfromregistersbyclinic
staff. Each clinic has a paper-based patient register provided by the
country Ministry of Health, on which visit date information is
captured.Clinicstaffrecordpatientswhotransfertoanotherclinicas
‘‘transfersout’’,andthosenotseenformorethanthreemonthsaslost
tofollow-upontheseforms;LTFpatientswhoreturntocarewillhave
their LTF designation removed from the register. Separate ‘‘ART
registers’’ are tabulated by clinic data clerks to retrospectively assess
whetherpatientsinitiatingART6and12monthsagoarealiveandon
ART duringthe current quarter.
Program-level exposure data. Availability of adherence
support and outreach services at each clinic, along with
information on the context in which each clinic operates, was
obtained from structured surveys administered by field staff in
June 2007, December 2007, and July 2008. Test-retest agreement
assessed for a subset of survey items at 58 clinics included in this
analysis was 83% overall (79% for adherence support questions,
74% for the outreach question) (data not presented).
Outcome Definitions
Attrition was defined as the sum of patients initiating ART who
were reported: 1) dead, 2) LTF, or 3) discontinued ART (even if
they remained in HIV care) during the reporting period. LTF was
defined as having no clinic visit in 3 months without documented
evidence of death or transfer to another clinic. In the cumulative
analysis, patients considered LTF as per above definition who
return to ART care were no longer considered LTF, while in the
cohort analysis such patients were LTF at 6 and 12 months
regardless of whether they subsequently returned thereafter to
ART care. Patients were classified as having died based on
information passively received by each clinic; no deaths were
independently ascertained.
Cumulative rates (attrition, LTF, death). Clinic person-
time on ART during each quarter was calculated by allotting 3
months of person-time for each patient on ART at the beginning
of a given quarter, and 1.5 months for patients initiating ART or
discontinuing ART (death, transfer, LTF, stopping ART) during
the quarter. Thus, all attrition and ART initiation was assumed to
occur at the middle of each quarter. These person-months were
summed across all quarters through December 2008 to obtain
cumulative clinic person-time on ART. Total attrition, death, and
LTF rates were computed by dividing the cumulative number of
attritions, deaths, or LTF, respectively, by the cumulative clinic
person-time on ART for each clinic. Rates through December
2008 were expressed per 100 person-years on ART. Figure 1
describes the method used to calculate clinic-level attrition, LTF,
and death rates using the example of total attrition.
For example, if 100 patients were active on ART at the
beginning of the study period (N0 in Figure 1, 25, 30, 35, and 30
patients newly initiated ART in Quarters 1, 2, 3, and 4,
respectively, and the total attrition was 5, 10, 15, and 10 patients
during Quarters 1, 2, 3, and 4, respectively, while there were no
transfers during this period, our cumulative attrition rate for this
clinic is calculated as:
Total attrition = Sum(Att1 to Att4)= 5 +10+15+10=40 patients
PM1=100patients*3months + 25patients*1.5months
– 5patients*1.5months =330 person- months
PM2=120patients*3months + 30patients*1.5months
– 10patients*1.5months =390 person-months
PM3=140patients*3months + 35patients*1.5months
– 15patients*1.5months =450 person-months
PM4=160patients*3months + 30patients*1.5months
– 10patients*1.5months =510 person-months
Cumulative attrition rate =40/(330+390+450+510)
=28.6 per 100 person-years
Cohort attrition 6 and 12 months following ART
initiation. Data on 6 and 12 month attrition was derived from
a subset of patients (83,389 of the 232,000 total patients) from
1,097 three-month cohorts of patients initiating ART. Cohorts
were included if data were available at both 6 and 12 months after
ART initiation, and cohort attrition was defined as the proportion
of patients not alive and on ART 6 and 12 months after ART
initiation at a given clinic.
Clinic Adherence and Outreach Services
Annual structured site assessments conducted at each clinic
captured information on clinic staffing and the availability of
support services. For this analysis, we focused on support services
targeting adherence to antiretroviral therapy and retention in care.
Clinics were queried on availability of the following categories of
adherence support services: ‘‘directed support services’’ involving
interaction with clinic staff (one-on-one or group adherence
counseling, on-site support groups, peer educator programs),
‘‘informational services’’ (written educational materials, reminder
tools), ‘‘pharmacy services’’ (routine medication pickup review,
presence of a dedicated ART pharmacist), and ‘‘structural
services’’ (food rations to support ART adherence). Each service
Attrition after ART Initiation, Sub-Saharan Africa
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Additionally, the total number of adherence support services
available at a given clinic (dichotomized at the lower quintile of
prevalence into .2 vs. #2) was constructed. Clinics reporting the
presence of a system to trace patients missing scheduled visits via
telephone, letters, or home visits were classified as having active
outreach.
Statistical Analyses
Cumulative clinic rates of total attrition, LTF, and death, as well
as 6 and 12 month attrition proportions for cohorts initiating
ART, were assessed in relation to clinic availability of adherence
and outreach services. Adjustments were made for clinic
characteristics thought to be plausibly associated with patient
outcomes (clinic population (cumulative number of patients
enrolled in care), location (urban/rural), facility type (primary,
secondary, tertiary), year of HIV program start, and year of ART
initiation (for cohort analyses)).
Log-linear models were used to estimate cumulative attrition,
LTF, and death rate ratios comparing clinics with and without
availability of each adherence support and outreach service. Both
unadjusted and adjusted models controlling for clinic character-
istics listed above were fit. Next, a ‘‘full’’ model was constructed to
assess the joint influence of each adherence and active outreach
service associated with the outcome of interest at alpha level #0.1.
For 6 and 12 months cohort attrition, risk ratios comparing
mean attrition proportions of cohorts at 6 and 12 months after
ART initiation were modeled using log-linear regression account-
ing for within-site correlation following methods described above.
A series of sensitivity analyses were conducted on our
cumulative and ART cohort analyses excluding years of data
collection and individual countries to estimate the influence on our
measures of association. These sensitivity analyses follow the same
procedures outlined above.
Results
232,000 patients initiated ART from 349 clinics in 10 countries
and were followed for 300,700 person-years. Most clinics were
situated at primary (47%) or secondary (48%) health facilities, and
57% were located in semi-urban or urban areas (Table 1). Kenya
contributed the most number of clinics (N=71 [20%]), while
Mozambique contributed the most number of patients (N=53,000
[23%]). Overall, 59% of the adults were female and 8% were
pediatric patients ,15 years of age.
Adherence Support and Outreach Services
Almost all clinics (93%) reported availability of at least one
adherence support service and 83% reported more than two; 53%
reported availability of active patient outreach (Table 2). Clinics
averaged availability of four adherence support services; specific
service availability at clinics ranged from 17% (food rations) to
88% (one-on-one and/or group counseling). Table 3 presents
cross-tabulated proportions showing the joint distribution of
adherence support and outreach services within the same facilities.
We found that adherence support services were not randomly
distributed across clinics. Rather, clinics with one service tended to
be more likely to have other services as well, although there is
substantial heterogeneity between clinics.
Outcomes
Of the 232,389 patients initiating ART during 2004- December
2008, 72% were still active on ART and attending the same clinic
at the end of the follow-up period. Of those no longer active on
ART as of December 2008, 20,348 (9%) transferred to another
clinic and attrition occurred among 44,428 (19%), including
14,678 (6.3%) who died, 2,148 (0.9%) discontinuing ART, and
27,602 (11.9%) LTF. The overall total attrition rate (measured as
specified in Figure 1) was 14.2 per 100 person-years (4.9 deaths,
0.7 discontinuations, and 9.2 LTF per 100 person-years). Among
the 6 and 12 month ART cohorts, attrition proportion were 20%
and 27%, respectively among the 82,981 patients included.
Total Attrition
In multivariate analyses (Table 4), clinics with .2 vs. #2
adherence support services available had marginally lower
attrition (RRadj=0.59, 95%CI: 0.35–1.0). For specific adherence
services, availability of educational materials (RRadj=0.73,
95%CI: 0.63–0.85), one-on-one and/or group adherence coun-
Figure 1. Schematic calculation of clinic-level attrition, LTF, and death rates using aggregate data. Ni = Number of patients active on
ART at the end of reporting quarter i. Newi = Number of patients newly initiating ART during reporting quarter i. Atti = Number of patients
attritioned (discontinued ART, lost to follow-up, or dead) during quarter i. Ti = Number of patients transferring to another clinic during quarter i.
doi:10.1371/journal.pone.0038443.g001
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(RRadj=0.79, 95%CI: 0.64–0.97), and food rations to support
ART adherence (RRadj=0.72, 95%CI: 0.58–0.90) were signifi-
cantly associated with lower attrition rates (Table 4). On-site
support groups, peer educator programs, pharmacy support
services and active patient outreach were not significantly
associated with attrition following ART initiation.
Loss to Follow-up
In multivariate analyses, clinics with .2 vs. #2 adherence
support services available had lower rates of LTF (RRadj =0.48,
95%CI: 0.25–0.92). For specific services, availability of educa-
tional materials (RRadj=0.63, 95%CI: 0.52–0.77) and adherence
counseling (RRadj=0.55, 95%CI: 0.33–0.89) was significantly
associated with lower rates of LTF. Availability of pharmacy
services including routine medication pickup review (RRadj=0.60,
95%CI: 0.36–1.0) was marginally associated with LTF, as was
availability of food rations (RRadj=0.65, 95%CI: 0.47–0.88).
Other service availability was not significantly associated with
LTF.
Deaths
In multivariate analyses (Table 4), availability of .2 vs. #2
adherence support services was not associated with reported death
rates. Among specific adherence services, availability of on-site
support groups (RRadj=0.81, 95%CI: 0.70–0.93), peer educators
(RRadj=0.84, 95%CI: 0.74–0.96) and reminder tools
(RRadj=0.81, 95%CI: 0.66–0.98) were significantly associated
with lower death rates, while availability of food rations to support
ART adherence was marginally associated with lower death rates
(RRadj=0.83, 95%CI: 0.69–1.0). Availability of adherence coun-
seling, educational materials, and pharmacy services were not
significantly associated with death rates at clinics.
Attrition in 6 and 12 Month Cohorts
In multivariate analyses of 6 and 12 months cohorts of patients
initiating ART (Table 5), availability of .2 vs. #2 adherence
support services had significantly lower cohort attrition at 6
months (RRadj=0.84, 95%CI: 0.73–0.96), but not 12 months
following ART initiation. Cohorts of patients initiating ART at
clinics offering pharmacy services including routine medication
pickup review were significantly associated with lower attrition at 6
months and marginally lower attrition at 12 months, respectively
(RRadj,6m=0.78, 95%CI: 0.69–0.90; RRadj,12m=0.85, 95%CI:
0.73–1.0). Cohorts of patients initiating ART at clinics with active
patient outreach had lower attrition at 6 and 12 months
(RRadj,6m=0.86, 95%CI: 0.73–0.99; RRadj,12m=0.84, 95%CI:
0.74–0.96, respectively). Availability of other services were not
significantly associated with 6 or 12 month attrition among cohorts
of patients initiating ART.
Adjustment for Multiple Adherence Support Services
In the ‘‘full’’ model including all services significant at an alpha
level of 0.1 (Table 6), availability of educational materials and food
rations remained significantly associated with lower rates of total
attrition and LTF, while availability of on-site support groups and
reminder tools remained significantly associated with lower death
rates.
For the ART cohort analysis, in the ‘‘full’’ model including all
adherence support services significant at an alpha level of 0.1
(Table 7), availability of pharmacy services remained significantly
associated with lower attrition at 6 months, while availability of
active patient outreach remained significantly associated at 12 but
not 6 months. Availability of food rations was not associated with 6
or 12 month attrition among cohorts of patients initiating ART.
Sensitivity analyses for both clinic- and cohort-level models
examining the impact of excluding the first year of data collection,
and separately excluding individual countries, were conducted to
assess the robustness of our findings. These analyses found no
substantial differences in the magnitude of point estimates,
although variability increased somewhat due to a reduced sample
size (data not shown).
Discussion
Most studies of adherence support interventions to date have
focused on interventions supporting medication adherence among
those receiving antiretroviral medications [14,17–24]. The focus of
this report aims at addressing the related and upstream issue of
retention of patients after initiation of ART, in recognition of the
importance of attrition in the context of large scale HIV programs,
which remains suboptimal [1,2,9,25–27]. Our findings demon-
strate that clinics with educational materials and food rations
available were significantly associated with lower attrition and
lower LTF compared with clinics without these services, while
clinics with availability of support groups, peer educators and
reminder tools for adherence were associated with lower rates of
measured death compared to clinics without these services. In
ART cohort analyses, pharmacy support was significantly
associated with lower 6 month attrition, and active outreach was
associated with lower 12 month attrition. These findings were
observed across clinics from diverse settings in sub-Saharan Africa
independent of other clinic characteristics (urban/rural, facility
type [primary, secondary, tertiary], patient load, and program
maturity).
Studies from sub Saharan Africa have attempted to better
define the outcomes of patients lost to follow-up. In our analyses,
65% of the observed attrition rate was due to LTF. A 2009 review
of studies tracing patients LTF from resource-limited settings
estimated that between 33–48% of such patients classified as LTF
had actually died, with substantial variability across studies and
populations [3]. Other studies have found substantial contribu-
tions from both undocumented deaths and undocumented
transfers to LTF [4,5,26,28–35]. This heterogeneity underscores
that there are many, perhaps divergent, reasons why patients
become LTF [36]. A key issue is the contribution of unascertained
death to losses to follow-up [4–6]. If clinics with higher LTF rates
are consequentially reporting proportionately fewer ‘‘true’’ deaths,
this would mask the relationship between service availability and
actual death through differential death reporting. Consequently, in
settings experiencing high loss to follow-up, we recommend using
the combined outcome of total attrition as the primary measure of
patient outcomes when using aggregate data. When using
individual-level data, nomogram approaches can be used for
correcting mortality rates for loss to follow-up [37,38].
In our analyses, we noted several discrepancies that may reflect
this complex interplay. Clinics with availability of educational
materials, one-on-one/group counseling, and reminder tools had
significantly lower rates of attrition and LTF, but were not
associated with measured death rates. In addition, clinics with
availability of support groups and peer educators had significantly
lower death rates but did not have lower rates of attrition or LTF.
Differentially lower ascertainment of the true number of deaths
among clinics offering these services (due to higher LTF in these
clinics) may partially explain these findings. Complete ascertain-
ment of causes of LTF is necessary in order to better understand
the associations identified in our analyses [39]. Barring this,
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through tracing studies or simulation, would help clarify the
complex relationship between LTF and death ascertainment.
Malnutrition and wasting have been associated with unfavor-
able HIV disease outcomes [14,40,41], and food insecurity may
adversely affect HIV related outcomes from two perspectives: as
a possible reason for non-adherence to ART (fear of hunger and
actual hunger coupled with food insecurity [13]) as well as a
structural barrier to retention [42,43] (lost wages from attending
clinic). In our analyses, clinics with availability of food rations
had significantly lower attrition and LTF rates in the cumulative
analysis, but had only a marginal effect on death rates, the latter
effect not retained in the full model analysis. It is possible that
under-ascertainment of deaths at facilities with higher LTF could
mask the true impact of food support services on survival. In the
cohort analyses, similar-magnitude but non-significant associa-
tions (compared to the cumulative analysis) were observed for
attrition at 6 months, but not 12 months. The inconsistent
findings may reflect unmeasured confounding (perhaps the 17%
of the clinics offering food rations were more likely to offer other
[unmeasured] services improving retention) or inconsistency
between cumulative and cohort-derived measures of retention.
Availability of services to track patients missing visits has been
associated with reduced LTF [14,44–46]. In our analyses,
however, clinics with availability of active outreach services did
not have lower attrition, LTF or death rates in the cumulative
analysis but they did have significantly lower attrition in the 12
month cohort analysis. The reason for this discrepancy may be
due to different definitions for these outcomes in the two types of
analyses we utilized (cumulative estimates, which carry with them
a clinic’s entire history with respect to retention and survival, and
cohort-estimates, which provide more time-defined estimates).
For specific adherence support services (adherence counseling
services, educational materials, and reminder tools) associations
were observed with lower attrition in the cumulative analyses but
not in the 6- and 12-month ART cohort analyses. It is important
to note that, as highlighted in Figure 1 and above, the cumulative
attrition rates are averages over an entire clinic’s reporting history,
and more weight is given to quarters in which more patients were
active in care. Although this average estimate accurately reflects
the average attrition rate for each clinic, it may not accurately
represent attrition rates at any one point in time, especially among
clinics experiencing rapid scale-up during the time period if this
scale up was also coupled with changing attrition. In contrast,
cohort attrition proportions estimate 6 and 12 month attrition
after ART initiation by following specific groups of patients
initiating ART in the same time period. Reporting on longitudinal
cohorts of patients initiating ART in a given time period and
followed up for 6 and 12 months is inherently a more difficult task
to complete, and not all clinics have the capability of doing this, or
were able to do this for the full population included in the
cumulative analysis. Thus, cohorts that were reported and thus
included in this analysis may be more similar in other aspects
impacting retention (such as proper reporting systems in place)
regardless of availability of these specific services such that
Table 6. ‘‘Full’’ model analysis: Risk and Rate Ratios for overall attrition, LTF and death adjusting for other adherence support
activities
1.
Adherence support services Attrition Rate Ratio
2 LTF Rate Ratio
2 Death Rate Ratio
2
one-on-one/group adherence counseling yes vs. no 0.77 (0.52–1.14) 0.72 (0.44–1.19) not in model
on-site support groups for HIV+ patients yes vs. no not in model not in model 0.82 (0.69–0.99)
peer educator program yes vs. no not in model not in model 0.89 (0.76–1.05)
Educational materials promoting ART adherence yes vs. no 0.76 (0.66–0.89) 0.67 (0.55–0.81) not in model
Reminder tools (e.g., clocks, calendars, pill boxes) yes vs. no 0.83 (0.67–1.03) 0.83 (0.63–1.11) 0.78 (0.64–0.94)
Routine medication pickup review, dedicated
or team pharmacist
yes vs. no 0.92 (0.62–1.38) 0.85 (0.50–1.42) not in model
Food rations to promote ART adherence yes vs. no 0.74 (0.60–0.92) 0.67 (0.49–0.91) 0.86 (0.71–1.04)
Active patient outreach program yes vs. no not in model not in model 1.12 (0.93–1.34)
1All models adjusted for year of ART initiation, facility type (primary, secondary, tertiary), facility location (urban/rural), and cumulative number of patients enrolled in
care.
2Rate ratios for total attrition, loss to follow-up, and death additionally adjusted for other adherence support and active outreach services listed in the above table.
doi:10.1371/journal.pone.0038443.t006
Table 7. ART cohort ‘‘full model’’ analysis: Adjusted1 Attrition Risk Ratio at 6 and 12 months, adjusting for other adherence
support activities
Adherence support services Attrition % through 6 months Attrition % through 12 months
RR
1 RR
1
Routine medication pickup review, dedicated
or team pharmacist
yes vs. no 0.81 (0.70–0.94) 0.87 (0.73–1.04)
Food rations to promote ART adherence yes vs. no 0.87 (0.67–1.12) 1.04 (0.83–1.31)
Active patient outreach program yes vs. no 0.87 (0.75–1.12) 0.84 (0.73–0.96)
1Percent attrition ratios (RRs) additionally adjusted for other adherence support and active outreach services listed in the above table.
doi:10.1371/journal.pone.0038443.t007
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fact differ from those observed in the cohort analyses.
Our study has a number of strengths. The use of routinely
collected programmatic data enabled inclusion of a large number
of patients from diverse HIV care and treatment clinics from 10
sub-Saharan African countries, representing approximately 8% of
all patients initiating ART in this region and time [47]. The large
number of clinics and contexts enabled examination of many
clinic-level characteristics. Our findings were robust to sensitivity
analyses, including exclusion of individual countries and cohorts
that initiated ART in 2004 and 2005. Finally, the use of two
different types of outcomes for retention (cumulative and cohort-
based measures) allows examination of the findings in the context
of the different limitations inherent in each approach.
There are also several limitations to our analyses. This was an
ecologic analysis of the impact of programmatic factors on
attrition, and therefore cannot adjust for differences in patient
characteristics across clinics and cohorts that also impact attrition,
such as CD4 count at ART initiation [38,48]. However, we also
note that programmatic factors likely act at least in part through
their impact on these individual-level factors. Additionally, our
analyses focused on reported presence or absence of various
services at clinics, and we are unable to investigate key issues such
as intensity and coverage of these services, per-patient service
frequency, or quality of the services provided. Also, while our
patient population consisted primarily of adults, 8% of our
population was pediatric patients, who may have different
determinants of attrition, LTF, and death. Due to limitations in
the routinely-collected data, we were unable to separate out our
aggregate population into adults and children. Also, while the
population of patients included in this report was followed between
2004 and 2008, clinic interviews for availability of services were
conducted in 2007 and 2008; some clinics with a different service
availability profile prior to the initial 2007 assessment may be
misclassified for part of the analysis period. Reported deaths could
not be confirmed and, as noted above, the lack of complete vital
status ascertainment in the context of high rates of LTF, warrants
caution in interpretation of associations with death rates. We
therefore place greater emphasis on the combined outcome of
attrition when assessing programmatic outcomes. For the cumu-
lative clinic-level attrition analyses, we note that data collected
over several years, used to calculate an overall average attrition
rate for each facility, may be subject to variable quality. Although
standardized data quality measures are in place at all clinics, and
data are reviewed routinely for errors and inconsistencies, it is
possible that the quality of the data, particularly recording of loss
to follow-up and mortality, differed within clinics across this time
period. We have no information to assess this possibility and this is
an important potential source of information bias in our
assessments. Finally, we note in Table 3 that the availability of
specific adherence support and outreach services is not distributed
randomly across all clinics: clinics reporting availability of one
service tend to be more likely to offer additional services as well.
While we accounted for this by (1) testing whether the presence of
more than 2 services was associated with attrition, LTF, and death
and (2) reporting on measures of association between specific
adherence services and these outcomes adjusting for other service
availability (Table 6), we acknowledge that co-linearity between
availability of support services limits our ability to separate out the
association of specific services.
In summary, acknowledging the important limitations discussed
above, our findings provide insights into the association between
the availability of various adherence support and outreach
activities and retention on ART in HIV programs in sub-Saharan
Africa. Further analyses using patient-level information and
measures of service utilization and quality would add further to
this study. However, a substantial proportion of sub-Saharan HIV
clinics do not have electronic patient-level data systems available,
and findings from such analyses may be less generalizable to HIV
scale-up clinics in the region. Thus broad ecological analyses of
service delivery data and analyses that utilize individual-level
information should be leveraged to provide complimentary
insights. Our analyses demonstrate the utility of routinely-collected
aggregate data for informing program evaluation and design, and
suggest that availability of adherence support services, active
patient outreach, and food rations at HIV care clinics may
improve retention following ART initiation.
Acknowledgments
All data utilized in these analyses reflect the dedication of the ICAP-
Columbia University staff and the partnership and guidance provided by
ministries of health from Cote d’Ivoire, Ethiopia, Kenya, Lesotho,
Mozambique, Nigeria, Rwanda, South Africa, Tanzania and Zambia
and other partners. Special acknowledgement to the following key staff at
ICAP in New York, NY: David Hoos, Elaine Abrams, Batya Elul, Robin
Flam, Jessica Justman, Miriam Rabkin and to the ICAP country directors:
Amy Cunningham, Mark Hawken, Josue Lima, Redempta Mbatia,
Tshiwela Neluheni, Raphael Ntumy, Bolanie Oyeledun, Blanche Pitt,
Ruben Sahabo, Ida Viho, and. Melaku Zenebe; Acknowledgement is also
due to Maria Lahuerta, Suzue Saito, Yingfeng Wu, Tsigereda Gadisa,
Muhsin Sherrif, Melanie Manyasha, Maria Fernanda Alvim, Frank
Oransaye, Veronicah Mugisha, Harriet Nuwagaba-Biribonwoha, Molly
Strachan, Kanchan Reed, and Hermann Brou; Special thanks to Sharon
Schwartz and Dan Herman for their comments on earlier versions of this
manuscript. We are also grateful to the anonymous reviewers whose
comments have substantially improved this manuscript.
Author Contributions
Conceived and designed the experiments: MRL DN. Performed the
experiments: MRL. Analyzed the data: MRL. Wrote the paper: MRL DN
WES EG.
References
1. Rosen S, Fox MP, Gill CJ (2007) Patient retention in antiretroviral therapy
programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298.
2. Fox MP, Rosen S (2010) Patient retention in antiretroviral therapy programs up
to three years on treatment in sub-Saharan Africa, 2007–2009: systematic
review. Trop Med Int Health 15 Suppl 1: 1–15.
3. Brinkhof MW, Pujades-Rodriguez M, Egger M (2009) Mortality of patients lost
to follow-up in antiretroviral treatment programmes in resource-limited settings:
systematic review and meta-analysis. PLoS One 4: e5790.
4. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, et al. (2010)
Understanding reasons for and outcomes of patients lost to follow-up in
antiretroviral therapy programs in Africa through a sampling-based approach.
J Acquir Immune Defic Syndr 53: 405–411.
5. Geng EH, Glidden DV, Emenyonu N, Musinguzi N, Bwana MB, et al. (2010)
Tracking a sample of patients lost to follow-up has a major impact on
understanding determinants of survival in HIV-infected patients on antiretro-
viral therapy in Africa. Trop Med Int Health 15 Suppl 1: 63–69.
6. Chesney MA (2000) Factors affecting adherence to antiretroviral therapy. Clin
Infect Dis 30 Suppl 2: S171–176.
7. Chesney MA, Morin M, Sherr L (2000) Adherence to HIV combination
therapy. Soc Sci Med 50: 1599–1605.
8. DiMatteo MR (2004) Variations in patients’ adherence to medical recommen-
dations: a quantitative review of 50 years of research. Med Care 42: 200–209.
9. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. (2006)
Adherence to HAART: a systematic review of developed and developing nation
patient-reported barriers and facilitators. PLoS Med 3: e438.
10. Sanjobo N, Frich JC, Fretheim A (2008) Barriers and facilitators to patients’
adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J
5: 136–143.
Attrition after ART Initiation, Sub-Saharan Africa
PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e3844311. Kip E, Ehlers VJ, van der Wal DM (2009) Patients’ adherence to anti-retroviral
therapy in Botswana. J Nurs Scholarsh 41: 149–157.
12. Murray LK, Semrau K, McCurley E, Thea DM, Scott N, et al. (2009) Barriers
to acceptance and adherence of antiretroviral therapy in urban Zambian
women: a qualitative study. AIDS Care 21: 78–86.
13. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, et al. (2007) Hunger,
waiting time and transport costs: time to confront challenges to ART adherence
in Africa. AIDS Care 19: 658–665.
14. Byron E, Gillespie S, Nangami M (2008) Integrating nutrition security with
treatment of people living with HIV: lessons from Kenya. Food Nutr Bull 29:
87–97.
15. Brinkhof M, Dabis F, Myer L, Bangsberg D, Boulle A, et al. (2008) Early loss to
program in HIV-infected patients starting potent antiretroviral therapy in lower-
income countries. PLOS Medicine in press.
16. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006)
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy:
comparison between low-income and high-income countries. Lancet 367:
817–824.
17. Demeester R, Omes C, Karasi JC, Schneider S, Mugabo J, et al. (2005)
Adherence to first-line antiretroviral regimens in Rwanda. J Acquir Immune
Defic Syndr 40: 113–114.
18. Fairley CK, Levy R, Rayner CR, Allardice K, Costello K, et al. (2003)
Randomized trial of an adherence programme for clients with HIV. Int J STD
AIDS 14: 805–809.
19. Goujard C, Bernard N, Sohier N, Peyramond D, Lancon F, et al. (2003) Impact
of a patient education program on adherence to HIV medication: a randomized
clinical trial. J Acquir Immune Defic Syndr 34: 191–194.
20. Milam J, Richardson JL, McCutchan A, Stoyanoff S, Weiss J, et al. (2005) Effect
of a brief antiretroviral adherence intervention delivered by HIV care providers.
J Acquir Immune Defic Syndr 40: 356–363.
21. Pradier C, Bentz L, Spire B, Tourette-Turgis C, Morin M, et al. (2003) Efficacy
of an educational and counseling intervention on adherence to highly active
antiretroviral therapy: French prospective controlled study. HIV Clin Trials 4:
121–131.
22. Torpey KE, Kabaso ME, Mutale LN, Kamanga MK, Mwango AJ, et al. (2008)
Adherence support workers: a way to address human resource constraints in
antiretroviral treatment programs in the public health setting in Zambia. PLoS
One 3: e2204.
23. Traore AA NV, McCarrick P, Dhaliwal M, Tioendrebeogo I, Ilboudo A (2004)
Barriers to adherence to ARV therapy in a community-based cohort in Burkina
Faso [Abstract]. XV International AIDS Conference. Bangkok, Thailand. pp.
AbstractWePeB5824 p.
24. Weber R, Christen L, Christen S, Tschopp S, Znoj H, et al. (2004) Effect of
individual cognitive behaviour intervention on adherence to antiretroviral
therapy: prospective randomized trial. Antivir Ther 9: 85–95.
25. Attaran A (2007) Adherence to HAART: Africans take medicines more faithfully
than North Americans. PLoS Med 4: e83.
26. Fox MP, Brennan A, Maskew M, MacPhail P, Sanne I (2010) Using vital
registration data to update mortality among patients lost to follow-up from ART
programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med
Int Health 15: 405–413.
27. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. (2006) Adherence
to antiretroviral therapy in sub-Saharan Africa and North America: a meta-
analysis. JAMA 296: 679–690.
28. An MW, Frangakis CE, Musick BS, Yiannoutsos CT (2009) The need for
double-sampling designs in survival studies: an application to monitor PEPFAR.
Biometrics 65: 301–306.
29. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, et al. (2008)
Overestimates of survival after HAART: implications for global scale-up efforts.
PLoS One 3: e1725.
30. Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, et al. (2008)
Characteristics and outcomes of adult patients lost to follow-up at an
antiretroviral treatment clinic in johannesburg, South Africa. J Acquir Immune
Defic Syndr 47: 101–107.
31. Deribe K, Hailekiros F, Biadgilign S, Amberbir A, Beyene BK (2008) Defaulters
from antiretroviral treatment in Jimma University Specialized Hospital,
Southwest Ethiopia. Trop Med Int Health 13: 328–333.
32. Maskew M, MacPhail P, Menezes C, Rubel D (2007) Lost to follow up:
contributing factors and challenges in South African patients on antiretroviral
therapy. S Afr Med J 97: 853–857.
33. Yiannoutsos CT, An MW, Frangakis CE, Musick BS, Braitstein P, et al. (2008)
Sampling-based approaches to improve estimation of mortality among patient
dropouts: experience from a large PEPFAR-funded program in Western Kenya.
PLoS One 3: e3843.
34. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, et al. (2007) True
outcomes for patients on antiretroviral therapy who are ‘‘lost to follow-up’’ in
Malawi. Bull World Health Organ 85: 550–554.
35. Fox MP, Brennan A, Maskew M, MacPhail P, Sanne I (2010) Using vital
registration data to update mortality among patients lost to follow-up from ART
programmes: evidence from the Themba Lethu Clinic, South Africa. Tropical
medicine & international health : TM & IH 15: 405–413.
36. Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, et al. (2010) Retention
in care among HIV-infected patients in resource-limited settings: emerging
insights and new directions. Current HIV/AIDS reports 7: 234–244.
37. Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, et al. (2011) Correcting
mortality for loss to follow-up: a nomogram applied to antiretroviral treatment
programmes in sub-Saharan Africa. PLOS Medicine 8: e1000390.
38. Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, et al. (2011) Patients
enrolled in HIV care in Mozambique: baseline characteristics and follow-up
outcomes. Journal of acquired immune deficiency syndromes 58: e75–86.
39. Geng EH, Glidden DV, Bangsberg DR, Bwana MB, Musinguzi N, et al. (2012)
A Causal Framework for Understanding the Effect of Losses to Follow-up on
Epidemiologic Analyses in Clinic-based Cohorts: The Case of HIV-infected
Patients on Antiretroviral Therapy in Africa. American journal of epidemiology.
40. de Pee S, Semba RD (2010) Role of nutrition in HIV infection: review of
evidence for more effective programming in resource-limited settings. Food and
nutrition bulletin 31: S313–344.
41. Kuria E (2010) Food consumption and nutritional status of people living with
HIV/AIDS (PLWHA): a case of Thika and Bungoma Districts, Kenya. Public
Health Nutrition 13: 475–479.
42. Nash D, Korves C, Saito S, Sherman S, Elul B, et al. (2007) Characteristics of
Facilities and Programs Delivering HIV Care and Treatment Services are
Associated with Loss to Follow-up Rates in Programs from 8 sub-Saharan
African Countries Conference on Retroviruses and Opportunistic Infections
(CROI) Boston, MA Abstract No. 838 p.
43. Anema A, Zhang W, Wu Y, Elul B, Weiser SD, et al. (2012) Availability of
nutritional support services in HIV care and treatment sites in sub-Saharan
African countries. Public health nutrition 15: 938–947.
44. Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, et al. (2010) Low
retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres
in West Africa. Tropical medicine & international health : TM & IH 15 Suppl 1:
34–42.
45. Forster M, Bailey C, Brinkhof MW, Graber C, Boulle A, et al. (2008) Electronic
medical record systems, data quality and loss to follow-up: survey of
antiretroviral therapy programmes in resource-limited settings. Bull World
Health Organ 86: 939–947.
46. Thomson KA, Cheti EO, Reid T (2011) Implementation and outcomes of an
active defaulter tracing system for HIV, prevention of mother to child
transmission of HIV (PMTCT), and TB patients in Kibera, Nairobi, Kenya.
Transactions of the Royal Society of Tropical Medicine and Hygiene 105:
320–326.
47. WHO, UNAIDS, UNICEF (2009) Towards universal access : scaling up priority
HIV/AIDS interventions in the health sector : progress report 2009.
48. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. (2008) Early
loss of HIV-infected patients on potent antiretroviral therapy programmes in
lower-income countries. Bulletin of the World Health Organization 86:
559–567.
Attrition after ART Initiation, Sub-Saharan Africa
PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e38443